Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy
Author(s) -
Michinari Hieda,
Satyam Sarma,
Christopher M. Hearon,
Katrin A. Dias,
Jose Martinez,
Mitchel Samels,
Braden Everding,
Dean Palmer,
Sheryl Livingston,
Margot Morris,
Erin J. Howden,
Benjamin D. Levine
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.119.040332
Subject(s) - medicine , cardiology , preload , pulmonary wedge pressure , heart failure , ejection fraction , left ventricular hypertrophy , heart failure with preserved ejection fraction , blood pressure , pulmonary hypertension , hemodynamics
Individuals with left ventricular hypertrophy (LVH) and elevated cardiac biomarkers in middle age are at high risk for the development of heart failure with preserved ejection fraction (HFpEF). However, it is unknown what the pathophysiological underpinnings of this high-risk state may be. We tested the hypothesis that patients with LVH and elevated cardiac biomarkers would demonstrate elevated left ventricular (LV) myocardial stiffness in comparison with healthy controls as a key marker for future HFpEF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom